- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
213
17 new
Companies with a Value score of at least 3, ordered by Value score
213 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
0QCO | €0.71 | -2.9% | -33.1% | €481.3m | €1.79 | PS1.8x | E73.2% | n/a | ||
0O9B | €8.29 | -1.4% | -0.5% | €1.8b | €11.80 | PS1.9x | E54.2% | 2.2% | ||
0J2O | US$44.79 | -25.0% | 14.7% | US$5.4b | US$62.42 | PE14.5x | E21.1% | n/a | ||
0HF9 | US$9.48 | -9.7% | -12.6% | US$2.9b | US$17.42 | PS5.8x | E66.6% | n/a | ||
HIK | UK£18.38 | 0.7% | 4.6% | UK£4.1b | UK£23.27 | PE18.1x | E12.8% | 3.4% | ||
HVO | UK£0.24 | -20.1% | 31.3% | UK£161.9m | UK£0.35 | PE9.3x | E-15.2% | 0.8% | ||
0R2M | US$741.73 | -9.3% | -6.8% | US$82.0b | US$1,073.95 | PE17.2x | E7.6% | n/a | ||
0ILL | €61.60 | -5.5% | 17.9% | €3.2b | €94.92 | PE19.1x | E19.6% | 1.8% | ||
0W4N | €47.05 | -1.4% | -23.9% | €820.2m | €86.77 | PE12.8x | E31.5% | n/a | ||
HIKL | UK£18.43 | 0.9% | 5.0% | UK£4.1b | UK£23.33 | PE18.1x | E12.8% | 3.4% | ||
0NM7 | €320.00 | -8.2% | 14.9% | €2.7b | €403.58 | PE19x | E10.8% | 0.4% | ||
0QAH | US$96.50 | -3.5% | -6.2% | US$244.3b | US$131.03 | PE20.1x | E15.6% | 3.2% | ||
0Y5E | US$26.65 | -0.4% | -12.8% | US$3.7b | US$35.02 | PS0.8x | E63.8% | 4.1% | ||
0NTI | €70.65 | -6.6% | -17.0% | €2.4b | €114.37 | PE21.4x | E21.7% | 1.8% | ||
0LER | US$16.57 | -3.5% | 74.8% | US$18.7b | US$22.05 | PS1.1x | E65.8% | 0% | ||
C4XD | UK£0.12 | 45.9% | -16.4% | UK£30.3m | UK£0.48 | PE2.9x | E-88.3% | n/a | ||
0K6R | US$118.06 | -7.4% | 8.3% | US$11.9b | US$161.99 | PE31.3x | E29.6% | n/a | ||
NOVNz | CHF 91.02 | -1.5% | 6.9% | CHF 182.1b | CHF 103.03 | PE17.5x | E7.0% | 3.5% | ||
COPNZ | CHF 62.10 | -3.3% | 60.3% | CHF 1.0b | CHF 96.68 | PE15.4x | E17.2% | 3.0% | ||
0H19 | SEK 9.60 | -5.5% | -36.7% | SEK 324.3m | SEK 18.89 | PS0.5x | E71.8% | n/a | ||
0K16 | US$12.06 | -4.2% | 27.4% | US$759.2m | US$23.57 | PS3.1x | E73.9% | n/a | ||
0A5V | US$12.97 | -0.2% | 37.5% | US$15.5b | US$13.00 | PS1x | E53.5% | 3.7% | ||
0QLR | CHF 91.06 | -1.4% | 7.2% | CHF 182.1b | CHF 103.07 | PE17.5x | E7.0% | 3.5% | ||
0TDF | US$35.42 | -5.0% | 6.2% | US$201.3b | US$42.96 | PE18.8x | E11.1% | 3.8% |